The two Merck & Co. executives were somber as the company plane pitched and rolled through the remnants of Hurricane Jeanne on the night of Sept. 28.
The turbulence outside the aircraft was an echo of the corporate tempest leading up to their trip.
For five days Merck had been struggling with what to do with frightening new data that showed that long-term use of their $2.5 billion arthritis drug Vioxx doubled the risk of heart attacks and strokes, confirming concerns raised by earlier studies.
